Marchex outlines 10% revenue growth and 10%+ EBITDA margin targets for 2026 as Archenia acquisition advances
Source: SeekingAlpha
2025-11-13 18:42:21 ET
More on Marchex
- Marchex, Inc. (MCHX) Q3 2025 Earnings Call Transcript
- Marchex, Inc. (MCHX) Q1 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Marchex
- Historical earnings data for Marchex
- Financial information for Marchex
Read the full article on Seeking Alpha
For further details see:
Marchex outlines 10% revenue growth and 10%+ EBITDA margin targets for 2026 as Archenia acquisition advances
Marchex Inc.
NASDAQ: MCHX
MCHX Trading
0.71% G/L:
$1.41 Last:
1,484 Volume:
$1.40 Open:
MCHX Latest News
March 09, 2026 08:30:00 am
PDS Health Enhances Marketing Performance with Marchex Conversation Intelligence
